We found that KRAS was less stable in MM than in colon or pancreatic cells (Fig. 4G, J–K) but that this stability in MM could possibly be increased by overexpression of a DUB not expressed in malignant plasma cells. This evidence concerns the gene KRAS and Miyoshi myopathy.